|
Phase I study of tazemetostat, an enhancer of zeste homolog-2 inhibitor, in pediatric pts with relapsed/refractory integrase interactor 1-negative tumors. |
|
|
Consulting or Advisory Role - Epizyme |
Travel, Accommodations, Expenses - Epizyme |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bayer; Lilly; Loxo; Novartis |
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst) |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - GE Healthcare; Johnson & Johnson; Teva; Varian Medical Systems |
Consulting or Advisory Role - Ventana Medical Systems |
Research Funding - Bayer (Inst); Ignyta (Inst); Lilly (Inst); Merck (Inst); Roche (Inst) |
Patents, Royalties, Other Intellectual Property - Patent for non-invasive methods of leukemia cell detection with MRI/MRS - Patent No. 8894975 |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Lilly (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bayer; Halozyme; Lilly; Merck; Roche; Tesaro |
Travel, Accommodations, Expenses - Bayer; Roche |
|
|
Employment - Kaiser Permanente (I) |
Consulting or Advisory Role - Roche/Genentech |
Research Funding - Epizyme (Inst); Novartis (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Janssen; Novartis; PureTech; Roche/Genentech |
Research Funding - AstraZeneca |
Expert Testimony - AstraZeneca |
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Novartis; Roche/Genentech |
Other Relationship - Abbvie; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Epizyme; Janssen; Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Lilly; Roche/Genentech |
Research Funding - Genentech/Roche (Inst); Novartis (Inst); Novartis (Inst) |
|
|
|
Stock and Other Ownership Interests - Epizyme |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Bayer |